disease progression

Type: Keyphrase
Name: disease progression
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

FDA approves Lilly's CYRAMZA to treat advanced gastric cancer

The US Food and Drug Administration (FDA) has approved Eli Lilly and Company's CYRAMZA (ramucirumab) as a single-agent treatment for patients with advanced or metastatic gastric cancer or gastroesophageal junction (GEJ) adenocarcinoma with disease progression ... [Published PBR - News - Apr 22 2014]
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

7 steps to eliminating the war analogy in cancer care

From a philosophical standpoint, one of the things I hate most about cancer is the use of “war” analogies. The “battle” may mobilize patients and families, but it may also interfere with education and informed decision making. And both patients and ... [Published KevinMD.com - Apr 22 2014]
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

Dexamethasone induces heat shock response and slows down disease progression in mouse and fly models of Huntington's disease

Huntington's disease (HD) is an inherited neurodegenerative disorder caused by abnormal expansion of glutamine repeats in the protein huntingtin. In HD brain, mutant huntingtin undergoes proteolytic processing, and its N-terminal fragment containing poly-glutamine ... [Published Bionity.com - Apr 22 2014]
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

[Articles] Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study

These preliminary data suggest progression of idiopathic pulmonary fibrosis is associated with the presence of specific members within the Staphylococcus and Streptococcus genera. Additional research will be needed to identify the specific bacterial species ... [Published The Lancet Respiratory Medicine online - Apr 22 2014]
First reported Apr 21 2014 - Updated Apr 21 2014 - 1 reports

Radiotracer acts as marker, predictor in aortic stenosis

The radiotracer 18F-sodium fluoride (18F-NaF) serves as a biomarker of calcification activity in patients with aortic stenosis and may predict disease progression, according to a study published in the March issue of Circulation: Cardiovascular Imaging ... [Published Cardiovascular Business - Apr 21 2014]
First reported Apr 21 2014 - Updated Apr 21 2014 - 1 reports

Genoa Pharmaceuticals, McMaster University report additional benefits of GP-101 for IPF patients

Genoa Pharmaceuticals, the leader in inhaled medicines for pulmonary fibrosis , and collaborators Drs. Martin Kolb and Kjetil Ask at McMaster University announced today additional measured advantages of inhaled GP-101 (aerosol pirfenidone) in the treatment ... [Published News-Medical.Net - Apr 21 2014]
First reported Apr 19 2014 - Updated Apr 19 2014 - 1 reports

Women's heart disease is deadly, often caught later than in men

According to Go Red for Women and the American Heart Association, heart disease kills about one woman every minute. It's the No. 1 killer of women in America, accounting for one out of every three deaths each year.While men and women are at risk for heart ... [Published Kentucky.com - Apr 19 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

Parkinson's disease

We are able to control muscle movement, in part, via the aid of a brain chemical called dopamine. One of the hallmarks of the movement disorder, Parkinson’s disease (PD), is the death of dopamine-producing nerve cells. The onset of this syndrome is insidious ... [Published Norwalk Patch - Apr 18 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Pediatric oncology: 9 studies that may change your approach

At present, there are about approximately 12 million cancer survivors in the United States, many of whom were diagnosed before the age of 21. During the last 30 years, improved treatments and better supportive care have resulted in more children surviving ... [Published Orthopedics Today - Apr 17 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Melanoma vaccine shows promise

Prolonged, repeated vaccination can slow or stop disease progression in patients with advanced melanoma, say South Australian researchers.Developed at the University of Adelaide, the Vaccinia Melanoma Cell Lysate (VMCL) vaccine was recently trialed in ... [Published 6minutes.net.au - Apr 17 2014]
First reported Mar 26 2014 - Updated Mar 27 2014 - 3 reports

Study points to potential culprit that kills motor neurons in ALS

Amyotrophic lateral sclerosis, also known as Lou Gehrig's disease, is marked by a cascade of cellular and inflammatory events that weakens and kills vital motor neurons in the brain and spinal cord. The process is complex, involving cells that ordinarily ... [Published News-Medical.Net - Mar 27 2014]
First reported Mar 26 2014 - Updated Mar 26 2014 - 2 reports

Minimally invasive treatment may slow disease progression of metastatic breast cancer in liver while maintaining quality of life

Ratings require JavaScript to be enabled. A minimally invasive treatment that delivers cancer-killing radiation directly to tumors shows promise in ... ... [Published Big News Network - Mar 26 2014]

Quotes

"We are pleased that the FDA has approved Cyramza for these patients. This is an aggressive disease that is difficult to treat, and the prognosis has typically been very poor."
...and commercializing orphan therapies to address significant medical needs," said Shlomo Dagan, Ph D , chief executive officer of Andromeda Biotech. "If the second Phase 3 study is positive, DiaPep277 could play an important role in immune intervention of Type 1 diabetes, as patients who have even modest preservation of pancreatic beta cell activity could achieve better control of their blood sugar and a reduced risk of long-term diabetes complications."
...of Imbruvica in relapsed and refractory CLL patients with a median of four prior therapies," said Bob Duggan, CEO and Chairman of Pharmacyclics. "Our team is currently exploring the clinical benefits of Imbruvica in 42 clinical trials, of which 10 are large Phase III studies in a broad variety of B-Cell malignancies. With each passing month, I am increasingly pleased with the launch progress we are making, in partnership with our colleagues at Janssen, as we bring Imbruvica to market for CLL and MCL patients across the United States."

More Content

All (851) | News (753) | Reports (0) | Blogs (87) | Audio/Video (0) | Fact Sheets (1) | Press Releases (5)
sort by: Date | Relevance
Pride-HD Study Enrolling Patients Globally to F... [Published PredictWallStreet - 34 mins ago]
Eli Lilly's Cyramza becomes first FDA-approved ... [Published Pharmaceutical Technology - 2 hours ago]
Surprising Role of Prions in Neurodegenerative ... [Published Brain Blogger - 3 hours ago]
Hyperion Therapeutics to Broaden Orphan Disease... [Published BusinessWeek - 6 hours ago]
Orion BioNetworks Hosts Rancho BioSciences Webi... [Published PRWeb - 7 hours ago]
Screening Practices to Promote Earlier Diagnosi... [Published Advance for NPs and PAs - 7 hours ago]
Thyroid cancer [Published Lancet - 8 hours ago]
Pharmacyclics to Present Phase III and Long Ter... [Published Individual.com - 9 hours ago]
Alkermes Reports Positive Phase 3 Study Results [Published 4 Traders - 9 hours ago]
Patent Issued for Compositions and Methods for ... [Published HispanicBusiness.com - 14 hours ago]
Management of Valvular Heart Disease in Adults [Published New England Journal of Medicine - 17 hours ago]
MOLECULAR MEDICINE : Findings from Medical Univ... [Published 4 Traders - 20 hours ago]
Prostate Cancer Tests May Prove Risky for Some ... [Published BusinessWeek - 21 hours ago]
Longest Follow-Up to Date Shows Active Surveill... [Published CancerConnect.com - 22 hours ago]
Top 10 TB myths busted [Published Nursing In Practice - Apr 23 2014]
US FDA approve ramucirumab for treating advance... [Published Ecancer Medicalscience - Apr 23 2014]
Gene within gene drives acute myeloid leukemia,... [Published Medical News Today - Apr 23 2014]
NICE rejects Kadcyla [Published Pharmafocus - Apr 23 2014]
One Toke Over the Line: Can Marijuana Help Stop... [Published Gay.com - Apr 23 2014]
MicroRNA-181a promotes tumor growth and liver m... [Published 7thSpace - Apr 23 2014]
Drinking coffee reduces chances of dying from l... [Published Natural News - Apr 23 2014]
Transcriptional Profiling of Mycobacterium tube... [Published PLoS medicine - Apr 23 2014]
US FDA approves Lilly's Cyramza to treat advanc... [Published PharmaBiz - Apr 23 2014]
Slide Show: AACR Annual Meeting 2014 [Published Cancernetwork.com - Apr 23 2014]
Eli Lilly's Cyramza Receives FDA Approval for T... [Published PharmTech.com - Apr 23 2014]
Use of SFRP-3 in the assessment of heart failure [Published PharmCast - Apr 23 2014]
Neoadjuvant targeted treatment shows feasibilit... [Published News-Medical.Net - Apr 22 2014]
MYRIAD GENETICS : to Announce Financial Results... [Published 4 Traders - Apr 22 2014]
Identification of stage specific genes associat... [Published Arthritis & Rheumatism - Apr 22 2014]
Heiko Braak, MD, Author Of Parkinson's Staging ... [Published TheStreet.com - Apr 22 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Surprising Role of Prions in Neurodegenerative ... [Published Brain Blogger - 3 hours ago]
Prions are infectious agents, but of a very unusual kind. Technically, they are just proteins with an incorrectly folded conformation. However, there is a major difference between just any misfolded proteins (which are common in nature) and prions. ...
Heiko Braak, MD, Author of Parkinson's Staging ... [Published PR Newswire: General Business - Apr 22 2014]
NEW YORK, April 22, 2014 /PRNewswire-USNewswire/ -- Heiko Braak, MD, who proposed a novel pathway of Parkinson's disease progression, is the recipient of the 2014 Robert A. Pritzker Prize for Leadership in Parkinson's Research, conferred annually by The ...
7 steps to eliminating the war analogy in cance... [Published KevinMD.com - Apr 22 2014]
From a philosophical standpoint, one of the things I hate most about cancer is the use of “war” analogies. The “battle” may mobilize patients and families, but it may also interfere with education and informed decision making. And both patients and ...
Reductions in neuronal peroxisomes in multiple ... [Published Multiple Sclerosis Journal current issue - Apr 22 2014]
Background: Peroxisomes are organelles in eukaryotic cells with multiple functions including the detoxification of reactive oxygen species, plasmalogen synthesis and β-oxidation of fatty acids. Recent evidence has implicated peroxisomal dysfunction in ...
FDA approves Lilly's CYRAMZA to treat advanced ... [Published PBR - News - Apr 22 2014]
The US Food and Drug Administration (FDA) has approved Eli Lilly and Company's CYRAMZA (ramucirumab) as a single-agent treatment for patients with advanced or metastatic gastric cancer or gastroesophageal junction (GEJ) adenocarcinoma with disease progression ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
PatientsLikeMe and Sage Bionetworks Launch Open... [Published PatientsLikeMe Press Release - Feb 05 2014]
NeuroPhage to Participate in World's First G8 D... [Published PR Newswire - Dec 03 2013]
Revalesio Initiates Phase IIa Study of RNS60 in... [Published PR Newswire - Nov 11 2013]
COMS Interactive Launches OPAL Award Program [Published PR Newswire - Oct 31 2013]
Foundation Venture Capital Group Portfolio Comp... [Published PR Newswire - Oct 28 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.